Entest Group Inc

[NoQuarter]

Excellent post Jack! Dr V knows what he's talking about. Now that the Divy is over ENTB will run to where it belongs. (usually running between 50-75% of BMSN.) There are a multitude of game-changing PR's just over the horizon. KOOS delivered on the Divy and the company's business plan states (as per the S-1 filed to the SEC) that they anticipate FDA IND approval to start human trials for HemaCellerate and IND submission for Dcellvax. Never mind the canine arthritis drug ENTB has been working on or the COPD treatment (you've seen the elephant commercials guys there is money to be made). There is a perfect storm brewing and we here at ENTB stand on the support of the 200MA thanks to Friday. IMHO this week will be an epic ride for all three companies. All the pieces have fallen into place at the same time!GLTA!!! GO ENTB/REGEN/BMSN!
NoQuarter